Global Top 500 Companies by Market Capitalization 2017, with Hengrui Medicine on the list

From: Updated: 2018-02-26 03:22

Recently,　Xinhua　Finance　released　the　list　of　the　Global　Top　500　Companies　by　market　capitalization　in　2017.　The　list　is　based　on　the　closing　data　of　December　31,　2017　and　ranked　according　to　the　market　capitalization　of　listed　companies.　From　an　industry　perspective,　there　are　45　medical　and　health　companies　on　the　list,　among　which　the　top　three　are　Johnson　&　Johnson,　Roche　Group　and　Pfizer.　And　Hengrui　Medicine　is　the　only　Chinese　company　on　the　list,　having　a　market　capitalization　of　$29.86　billion.
Hengrui　has　always　been　adhering　to　the　two　strategic　directions　of　scientific　and　technological　innovation　and　internationalization.　And　the　accumulation　of　innovative　varieties　has　much　to　do　with　Hengrui’s　continuously　increasing　investment　in　research　and　development.　Its　annual　R　&　D　investment　accounts　for　about　10%　of　the　sales　revenue,　and　the　R　&　D　investment　in　2016　exceeded　1　billion　yuan.　In　the　first　half　of　2017　alone,　Hengrui　spent　782　million　yuan　on　research　and　development,　an　increase　of　60.03%　over　the　same　period.　A　virtuous　circle　has　been　formed　between　Hengrui’s　strong　R　&　D　capability　and　market　gains　in　the　context　of　the　reform　of　drug　review　and　approval　to　encourage　innovation.